STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 billion.